Stifel Financial Corp Nautilus Biotechnology, Inc. Transaction History

Stifel Financial Corp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$2.21 - $4.52 $1,783 - $3,647	-807 Reduced 5.82%	13,063 $50,000
Q1 2023 May 12, 2023	SELL	$1.67 - $2.77 $980 - $1,625	-587 Reduced 4.06%	13,870 $38,000
Q4 2022 Feb 13, 2023	SELL	$1.55 - $2.47 $7,742 - $12,337	-4,995 Reduced 25.68%	14,457 $26,000
Q3 2022 Nov 14, 2022	BUY	$1.96 - $3.13 $9,008 - $14,385	4,596 Added 30.94%	19,452 $41,000
Q2 2022 Aug 15, 2022	SELL	$2.64 - $4.84 $7,920 - $14,520	-3,000 Reduced 16.8%	14,856 $40,000
Q1 2022 May 13, 2022	BUY	$3.5 - $5.3 $21,000 - $31,800	6,000 Added 50.61%	17,856 $77,000
Q4 2021 Feb 14, 2022	BUY	$4.45 - $6.21 $4,650 - $6,489	1,045 Added 9.67%	11,856 $61,000
Q3 2021 Nov 15, 2021	BUY	$6.14 - $10.1 $66,379 - $109,191	10,811 New	10,811 $66,000

64.3M

1.9K

100

Ticker NAUT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,663,000
Market Cap $297M
Description
Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was found...

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Stifel Financial Corp with notifications on news.